GSK unveils ambitious growth targets after pressure from activist fund Elliott. But is this enough?
June 23, 2021 at 09:09 AM EDT
CEO Emma Walmsley, facing the possibility of a shareholder revolt, wants to boost profits at the pharmaceutical giant by 10% each year until 2026.
